Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bipartisan Support For AdvaMed’s Legislative Priorities, Whitaker Says

14 Oct 2022

• By Brian Bossetta

legislation — • Source: Shutterstock

Related Content

‘Skinny’ User-Fee Reauthorization Would Leave Out Diagnostics Reform

14 Jul 2022

Senate HELP Committee Passes User Fee Package

15 Jun 2022

Senate Bill Establishes Greater Regulatory Oversight Of Lab Developed Tests

18 May 2022

FDA Updates COVID-19 Test Policy; Shifts Focus From EUAs

27 Sep 2022

Additional Topics

United States FDA Policy Legislation Innovation Lobbying Manufacturing Politics Regulation Diagnostic Imaging Diagnostics Durable Medical Equipment In Vitro Diagnostics Standards Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.